The American Medical Association Digs in Its Heels on Pediatric Gender Transition

The American Medical Association (AMA) has recently reinforced its support for youth gender transition through a new policy. This decision has sparked considerable debate about the ethics and safety of this practice in pediatric medicine.

In August 2026, during its annual meeting, the AMA adopted a policy titled "Gender Affirming Healthcare and Research," which supports medical transition for youth and advocates for restoring research funding in this area.

The policy allows for surgical interventions as part of "affirming care" without specifying a minimum age for treatment.

Critics point to a conflict between evidence-based medicine and the push for patient autonomy in treatment access.

The AMA faced criticism after a previous statement aligned with the American Society of Plastic Surgeons recommending deferrals on surgeries for minors, indicating skepticism about their safety.

Ongoing research and systematic reviews in countries like the U.K., Sweden, and Finland have raised concerns about the long-term efficacy and safety of pediatric medical transitions, with evidence suggesting significant risks and potential harm.

Concerns have been voiced about conducting clinical trials on minors, as many medical professionals argue it is unethical to expose them to treatments with known risks before fully understanding the progress of gender dysphoria without medical intervention.

Despite the evidence against pediatric medical transition, the AMA's reaffirmation of its stance raises questions about the integrity of medical associations and their policies, as they seem to prioritize the interests of gender medicine advocacy.

The AMA's decision to uphold its support for youth gender transition raises ethical concerns amidst growing evidence of risks involved. Critics argue that the focus on patient autonomy does not account for the first principle of medical ethics: “do no harm. ” The ongoing debate reflects broader tensions in healthcare regarding treatment for minors amid insufficient data on safety and efficacy. 

https://www.city-journal.org/article/american-medical-association-pediatric-gender-transition-medicine